New brain aneurysm device tracked for 5 years in 500 patients
NCT ID NCT06368622
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 500 people who received the Surpass Evolve flow diverter, a device placed in brain arteries to treat aneurysms. Researchers will track safety and effectiveness for up to 5 years, focusing on stroke risk and aneurysm closure. The goal is to confirm the device works well in real-world use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Surpass Evolve Flow Diverter System (a mesh tube placed inside the artery to block blood flow to the aneurysm)
- What this could lead to
- If successful, this study could confirm that the Surpass Evolve device safely and effectively treats brain aneurysms over the long term, supporting its continued use.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be less definitive. Risks include stroke, device-related complications, and the possibility that long-term outcomes may not meet expectations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACRANIAL ANEURYSM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Chao-Yang Hospital, Capital Medical University
Beijing, China
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, 100070, China
-
Bethune First Hospital of Jilin University
Changchun, 130021, China
-
First Affiliated Hospital of Kunming Medical University
Kunming, 650032, China
-
Guangdong Second Provincial General Hospital
Guangzhou, China
-
Nanyang Central Hospital
Nanyang, China
-
Ningbo Medical Center Lihuili Hospital
Ningbo, 315048, China
-
Peking University Third Hospital
Beijing, 100191, China
-
Shanghai Fourth People's Hospital Affiliated To Tongji University
Shanghai, 200434, China
-
South China Hospital of Shenzhen University
Shenzhen, 518111, China
-
Tangshan Workers' Hospital
Tangshan, 063000, China
-
The Affiliated Hospital of Qingdao University
Qingdao, 266003, China
-
The Affiliated Hospital of Qingdao University
Qingdao, 266100, China
-
The Affiliated Hospital of Qingdao University
Qingdao, 266500, China
-
The Eighth Affiliated Hospital, Sun Yat-sen University (Shenzhen Futian)
Shenzhen, China
-
The Fifth Affiliated Hospital, Sun Yat-sen University
Zhuhai, China
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, 710061, China
-
The Third Hospital of Hebei Medical University
Shijiazhuang, 050051, China
-
Tianjin Huanhu Hospital
Tianjin, China
-
Weifang People's Hospital
Weifang, China
-
Xiangyang No.1 People's Hospital
Xiangyang, 441000, China
-
Xuanwu Hospital Capital Medical University
Beijing, 100053, China
-
Zhuhai People's Hospital
Zhuhai, 519000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI could sharpen the art of brain aneurysm repair
- Pompe disease may raise risk of brain aneurysms, new study investigates
- AI eye on brain bulges: software aims to spot hidden aneurysms
- 3D-Printed brain models could make aneurysm repair safer
- New study tests brain aneurysm device in Real-World settings
- New device aims to seal brain aneurysms without surgery